Publication charges for this article were waived due to the ongoing pandemic of COVID-19.
Lu R et al. 2020. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395: 565–574.
Richardson S et al. 2020. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323: 2052–2059.
Zhu L et al. 2020. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31: 1068–1077.e3.
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y, 2020. Prevalence and severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol 127: 104371.
Lee JS et al. 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol 5: eabd1554.
Hadjadj J et al. 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369: 718–724.
World Health Organization, 2020. Clinical Management of COVID-19. Geneva, Switzerland: WHO. WHO Reference Number: WHO/2019-nCoV/clinical/2020.5.
Kwon JS et al. 2018. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol 101: 57–62.
Peiris JSM et al. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361: 1767–1772.
Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, Peiris M, Poon LLM, Zhang W, 2020. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 20: 656–657.
Zheng S et al. 2020. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: retrospective cohort study. BMJ 369: m1443.
Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, Kim HM, Han MG, Kim SY, Chin BS, 2020. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci 35: e86.
Wang Y et al. 2020. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest 130: 5235–5244.
Chi Y et al. 2020. Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 (COVID-19) in China. J Infect Dis 222: 746–754.
RECOVERY collaborative Group Horby P et al. 2020. Dexamethasone in hospitalized patients with COVID-19 – preliminary report. N Engl J Med (Epub ahead of print). doi: 10.1056/NEJMoa2021436.
Zhou Z et al. 2020. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27: 883–890.e2.